nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0572	0.332	CbGbCtD
Dantrolene—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0532	0.308	CbGbCtD
Dantrolene—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0244	0.142	CbGbCtD
Dantrolene—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0224	0.13	CbGbCtD
Dantrolene—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0153	0.0885	CbGbCtD
Dantrolene—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000938	0.00113	CcSEcCtD
Dantrolene—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000936	0.00113	CcSEcCtD
Dantrolene—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000936	0.00113	CcSEcCtD
Dantrolene—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000924	0.00112	CcSEcCtD
Dantrolene—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000923	0.00112	CcSEcCtD
Dantrolene—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000923	0.00112	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000923	0.00112	CcSEcCtD
Dantrolene—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000922	0.00111	CcSEcCtD
Dantrolene—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000922	0.00111	CcSEcCtD
Dantrolene—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000922	0.00111	CcSEcCtD
Dantrolene—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00092	0.00111	CcSEcCtD
Dantrolene—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000917	0.00111	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000915	0.00111	CcSEcCtD
Dantrolene—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000913	0.0011	CcSEcCtD
Dantrolene—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000912	0.0011	CcSEcCtD
Dantrolene—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000911	0.0011	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000911	0.0011	CcSEcCtD
Dantrolene—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000905	0.00109	CcSEcCtD
Dantrolene—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000905	0.00109	CcSEcCtD
Dantrolene—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000904	0.00109	CcSEcCtD
Dantrolene—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000902	0.00109	CcSEcCtD
Dantrolene—Malaise—Etoposide—peripheral nervous system neoplasm	0.000895	0.00108	CcSEcCtD
Dantrolene—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000894	0.00108	CcSEcCtD
Dantrolene—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000888	0.00107	CcSEcCtD
Dantrolene—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000887	0.00107	CcSEcCtD
Dantrolene—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000887	0.00107	CcSEcCtD
Dantrolene—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000884	0.00107	CcSEcCtD
Dantrolene—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000884	0.00107	CcSEcCtD
Dantrolene—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000884	0.00107	CcSEcCtD
Dantrolene—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000877	0.00106	CcSEcCtD
Dantrolene—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000875	0.00106	CcSEcCtD
Dantrolene—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00087	0.00105	CcSEcCtD
Dantrolene—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00087	0.00105	CcSEcCtD
Dantrolene—Rash—Topotecan—peripheral nervous system neoplasm	0.00087	0.00105	CcSEcCtD
Dantrolene—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000869	0.00105	CcSEcCtD
Dantrolene—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000869	0.00105	CcSEcCtD
Dantrolene—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000865	0.00105	CcSEcCtD
Dantrolene—Headache—Topotecan—peripheral nervous system neoplasm	0.000864	0.00104	CcSEcCtD
Dantrolene—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.00104	CcSEcCtD
Dantrolene—Rash—Tretinoin—peripheral nervous system neoplasm	0.000863	0.00104	CcSEcCtD
Dantrolene—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000862	0.00104	CcSEcCtD
Dantrolene—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000862	0.00104	CcSEcCtD
Dantrolene—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000862	0.00104	CcSEcCtD
Dantrolene—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000862	0.00104	CcSEcCtD
Dantrolene—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000859	0.00104	CcSEcCtD
Dantrolene—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000859	0.00104	CcSEcCtD
Dantrolene—Headache—Tretinoin—peripheral nervous system neoplasm	0.000857	0.00104	CcSEcCtD
Dantrolene—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000857	0.00104	CcSEcCtD
Dantrolene—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000856	0.00103	CcSEcCtD
Dantrolene—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000855	0.00103	CcSEcCtD
Dantrolene—Pain—Vincristine—peripheral nervous system neoplasm	0.000855	0.00103	CcSEcCtD
Dantrolene—Constipation—Vincristine—peripheral nervous system neoplasm	0.000855	0.00103	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.00103	CcSEcCtD
Dantrolene—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.00103	CcSEcCtD
Dantrolene—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.00103	CcSEcCtD
Dantrolene—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000854	0.00103	CcSEcCtD
Dantrolene—Rash—Melphalan—peripheral nervous system neoplasm	0.000852	0.00103	CcSEcCtD
Dantrolene—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000851	0.00103	CcSEcCtD
Dantrolene—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000848	0.00102	CcSEcCtD
Dantrolene—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000842	0.00102	CcSEcCtD
Dantrolene—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000834	0.00101	CcSEcCtD
Dantrolene—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000824	0.000996	CcSEcCtD
Dantrolene—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000824	0.000995	CcSEcCtD
Dantrolene—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00082	0.000991	CcSEcCtD
Dantrolene—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00082	0.000991	CcSEcCtD
Dantrolene—Nausea—Topotecan—peripheral nervous system neoplasm	0.000819	0.00099	CcSEcCtD
Dantrolene—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000817	0.000987	CcSEcCtD
Dantrolene—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000816	0.000986	CcSEcCtD
Dantrolene—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000814	0.000984	CcSEcCtD
Dantrolene—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000813	0.000982	CcSEcCtD
Dantrolene—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000813	0.000982	CcSEcCtD
Dantrolene—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00081	0.000978	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000805	0.000973	CcSEcCtD
Dantrolene—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000803	0.00097	CcSEcCtD
Dantrolene—Nausea—Melphalan—peripheral nervous system neoplasm	0.000802	0.000969	CcSEcCtD
Dantrolene—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000798	0.000964	CcSEcCtD
Dantrolene—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000793	0.000958	CcSEcCtD
Dantrolene—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00079	0.000955	CcSEcCtD
Dantrolene—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00079	0.000955	CcSEcCtD
Dantrolene—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00079	0.000955	CcSEcCtD
Dantrolene—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00079	0.000955	CcSEcCtD
Dantrolene—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000783	0.000946	CcSEcCtD
Dantrolene—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000772	0.000932	CcSEcCtD
Dantrolene—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000768	0.000928	CcSEcCtD
Dantrolene—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000765	0.000925	CcSEcCtD
Dantrolene—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000764	0.000923	CcSEcCtD
Dantrolene—Pain—Cisplatin—peripheral nervous system neoplasm	0.000756	0.000913	CcSEcCtD
Dantrolene—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.00091	CcSEcCtD
Dantrolene—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000744	0.000899	CcSEcCtD
Dantrolene—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000738	0.000892	CcSEcCtD
Dantrolene—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000737	0.000891	CcSEcCtD
Dantrolene—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000736	0.00089	CcSEcCtD
Dantrolene—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000734	0.000887	CcSEcCtD
Dantrolene—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.000883	CcSEcCtD
Dantrolene—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000728	0.00088	CcSEcCtD
Dantrolene—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00072	0.00087	CcSEcCtD
Dantrolene—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000717	0.000866	CcSEcCtD
Dantrolene—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000712	0.00086	CcSEcCtD
Dantrolene—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000711	0.000859	CcSEcCtD
Dantrolene—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00071	0.000857	CcSEcCtD
Dantrolene—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000705	0.000852	CcSEcCtD
Dantrolene—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000704	0.00085	CcSEcCtD
Dantrolene—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000699	0.000845	CcSEcCtD
Dantrolene—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000699	0.000844	CcSEcCtD
Dantrolene—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000698	0.000843	CcSEcCtD
Dantrolene—Constipation—Etoposide—peripheral nervous system neoplasm	0.000692	0.000836	CcSEcCtD
Dantrolene—Pain—Etoposide—peripheral nervous system neoplasm	0.000692	0.000836	CcSEcCtD
Dantrolene—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.000829	CcSEcCtD
Dantrolene—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000684	0.000826	CcSEcCtD
Dantrolene—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000682	0.000824	CcSEcCtD
Dantrolene—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000682	0.000824	CcSEcCtD
Dantrolene—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000678	0.00082	CcSEcCtD
Dantrolene—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000667	0.000806	CcSEcCtD
Dantrolene—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000664	0.000803	CcSEcCtD
Dantrolene—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000662	0.0008	CcSEcCtD
Dantrolene—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000661	0.000798	CcSEcCtD
Dantrolene—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000659	0.000797	CcSEcCtD
Dantrolene—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000658	0.000795	CcSEcCtD
Dantrolene—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00079	CcSEcCtD
Dantrolene—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000653	0.000789	CcSEcCtD
Dantrolene—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000651	0.000787	CcSEcCtD
Dantrolene—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00065	0.000785	CcSEcCtD
Dantrolene—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000782	CcSEcCtD
Dantrolene—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000643	0.000777	CcSEcCtD
Dantrolene—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000642	0.000776	CcSEcCtD
Dantrolene—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00064	0.000773	CcSEcCtD
Dantrolene—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00064	0.000773	CcSEcCtD
Dantrolene—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000772	CcSEcCtD
Dantrolene—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000772	CcSEcCtD
Dantrolene—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000635	0.000768	CcSEcCtD
Dantrolene—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000634	0.000766	CcSEcCtD
Dantrolene—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.000763	CcSEcCtD
Dantrolene—Rash—Vincristine—peripheral nervous system neoplasm	0.00063	0.000761	CcSEcCtD
Dantrolene—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00063	0.000761	CcSEcCtD
Dantrolene—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000758	CcSEcCtD
Dantrolene—Headache—Vincristine—peripheral nervous system neoplasm	0.000626	0.000756	CcSEcCtD
Dantrolene—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000616	0.000744	CcSEcCtD
Dantrolene—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000616	0.000744	CcSEcCtD
Dantrolene—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000605	0.000731	CcSEcCtD
Dantrolene—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000596	0.000721	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000718	CcSEcCtD
Dantrolene—Nausea—Vincristine—peripheral nervous system neoplasm	0.000594	0.000717	CcSEcCtD
Dantrolene—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000716	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.000714	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.000714	CcSEcCtD
Dantrolene—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000581	0.000702	CcSEcCtD
Dantrolene—Chills—Epirubicin—peripheral nervous system neoplasm	0.000573	0.000692	CcSEcCtD
Dantrolene—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000573	0.000692	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00057	0.000688	CcSEcCtD
Dantrolene—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000562	0.000679	CcSEcCtD
Dantrolene—Rash—Cisplatin—peripheral nervous system neoplasm	0.000557	0.000673	CcSEcCtD
Dantrolene—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000557	0.000673	CcSEcCtD
Dantrolene—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000556	0.000672	CcSEcCtD
Dantrolene—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000554	0.000669	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000663	CcSEcCtD
Dantrolene—Tension—Epirubicin—peripheral nervous system neoplasm	0.000546	0.000659	CcSEcCtD
Dantrolene—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000658	CcSEcCtD
Dantrolene—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00054	0.000653	CcSEcCtD
Dantrolene—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000538	0.00065	CcSEcCtD
Dantrolene—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000535	0.000647	CcSEcCtD
Dantrolene—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.000641	CcSEcCtD
Dantrolene—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000525	0.000634	CcSEcCtD
Dantrolene—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000633	CcSEcCtD
Dantrolene—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000623	CcSEcCtD
Dantrolene—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000515	0.000622	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000622	CcSEcCtD
Dantrolene—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000621	CcSEcCtD
Dantrolene—Rash—Etoposide—peripheral nervous system neoplasm	0.00051	0.000617	CcSEcCtD
Dantrolene—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00051	0.000616	CcSEcCtD
Dantrolene—Headache—Etoposide—peripheral nervous system neoplasm	0.000507	0.000613	CcSEcCtD
Dantrolene—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.00061	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.000609	CcSEcCtD
Dantrolene—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000606	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.0005	0.000604	CcSEcCtD
Dantrolene—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000601	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000601	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000586	CcSEcCtD
Dantrolene—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000582	CcSEcCtD
Dantrolene—Nausea—Etoposide—peripheral nervous system neoplasm	0.000481	0.000581	CcSEcCtD
Dantrolene—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00048	0.00058	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000577	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.000575	CcSEcCtD
Dantrolene—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000572	CcSEcCtD
Dantrolene—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000565	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000561	CcSEcCtD
Dantrolene—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000559	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000556	CcSEcCtD
Dantrolene—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000458	0.000553	CcSEcCtD
Dantrolene—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000548	CcSEcCtD
Dantrolene—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.000539	CcSEcCtD
Dantrolene—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000537	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000444	0.000537	CcSEcCtD
Dantrolene—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000535	CcSEcCtD
Dantrolene—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000439	0.00053	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000529	CcSEcCtD
Dantrolene—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000523	CcSEcCtD
Dantrolene—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000523	CcSEcCtD
Dantrolene—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000518	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000512	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000507	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000413	0.0005	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000497	CcSEcCtD
Dantrolene—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000496	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000495	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.00049	CcSEcCtD
Dantrolene—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000487	CcSEcCtD
Dantrolene—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000484	CcSEcCtD
Dantrolene—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000483	CcSEcCtD
Dantrolene—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000477	CcSEcCtD
Dantrolene—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000473	CcSEcCtD
Dantrolene—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000469	CcSEcCtD
Dantrolene—Pain—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000469	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000462	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000459	CcSEcCtD
Dantrolene—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000452	CcSEcCtD
Dantrolene—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000451	CcSEcCtD
Dantrolene—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000448	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000447	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000441	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000437	CcSEcCtD
Dantrolene—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000436	CcSEcCtD
Dantrolene—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000434	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000434	CcSEcCtD
Dantrolene—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000433	CcSEcCtD
Dantrolene—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000433	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000418	CcSEcCtD
Dantrolene—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000415	CcSEcCtD
Dantrolene—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000404	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000403	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000401	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000401	CcSEcCtD
Dantrolene—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000393	CcSEcCtD
Dantrolene—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000388	CcSEcCtD
Dantrolene—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000375	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000374	CcSEcCtD
Dantrolene—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000364	CcSEcCtD
Dantrolene—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000363	CcSEcCtD
Dantrolene—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000359	CcSEcCtD
Dantrolene—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000349	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000347	CcSEcCtD
Dantrolene—Rash—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000346	CcSEcCtD
Dantrolene—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000345	CcSEcCtD
Dantrolene—Headache—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000343	CcSEcCtD
Dantrolene—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000335	CcSEcCtD
Dantrolene—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000326	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000323	CcSEcCtD
Dantrolene—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00032	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00032	CcSEcCtD
Dantrolene—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000318	CcSEcCtD
Dantrolene—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000301	CcSEcCtD
